http://purl.org/np/RA9EAQSYqh... RA9EAQSYqh

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

https://dailymed.nlm.nih.gov/d...00-e973-4bab-810c-b69f6c8ee4f3 drugInfo.cfm?setid=d6f08000-e973-4bab-810c-b69f6c8ee4f3

Leoni Bücken

2021-04-03T09:46:41.996Z

http://purl.org/np/RA9EAQSYqh... RA9EAQSYqh

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#value value

Additionally, [Trihexyphenidyl] is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.

Leoni Bücken

2021-04-03T09:46:41.996Z

http://purl.org/np/RA9EAQSYqh... RA9EAQSYqh

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://purl.org/np/RA9EAQSYqh...#medtherapy medtherapy

http://www.w3.org/ns/prov#wasDerivedFrom wasDerivedFrom

Leoni Bücken

2021-04-03T09:46:41.996Z